Most Recent

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

image: Death by Lab-Acquired Infection?

Death by Lab-Acquired Infection?

By | May 8, 2012

A researcher dead from a meningococcal infection may have acquired it in his laboratory.

6 Comments

image: Gene Signaling by Remote

Gene Signaling by Remote

By | May 7, 2012

Nanoparticles in mice can be switched on to activate insulin production using a radio signal.

0 Comments

image: First Drug from GM Plant Approved

First Drug from GM Plant Approved

By | May 4, 2012

A human enzyme grown in carrot cells will treat patients with Gaucher disease.

10 Comments

image: Six Threats to Chromosomes

Six Threats to Chromosomes

By | May 3, 2012

Researchers identify two new DNA repair systems, in addition to four that were already known, that can attack unprotected telomeres.

5 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: FDA Disputes Data Under-Reporting

FDA Disputes Data Under-Reporting

By | May 2, 2012

The FDA and NIH dispute reports that clinical trial data is being under-reported.

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

Contributors

May 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Treating Fat with Fat

Treating Fat with Fat

By | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech